Position in TNGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$125,057,724
-$42,302,547 QoQ
Shares Held
4,000,567
-50.0% QoQ
Ownership
2.37%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#18
of 246 holders
Holding Since
Sep 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. TNGX ranks #3 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
This page
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in TNGX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $125,057,724 | 4,000,567 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $125,057,724 | 4,000,567 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $167,360,271 | 8,000,013 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $167,360,271 | 8,000,013 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $89,239,913 | 10,072,225 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $50,651,395 | 6,029,928 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,873,118 | 6,029,906 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $693,477 | 506,188 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,218,686 | 394,397 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $2,986,620 | 348,091 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $2,815,000 | 250,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $875,301 | 263,645 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,426,716 | 361,194 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,647,961 | 365,236 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,810,343 | 500,095 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,265,430 | 500,095 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,790,720 | 500,095 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,470,196 | 500,018 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,465,517 | 500,040 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||